COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Eidos Therapeutics is a San Francisco–based clinical-stage biopharmaceutical company developing AG10, an oral small-molecule transthyretin stabilizer for ATTR, advancing from Phase 2 toward Phase 3 with BridgeBio collaboration.
